Single-center study shows thrombolysis and thrombectomy have similar safety profiles and outcomes in arteriovenous fistulas, suggesting a focus on individualized treatment.
In thrombosed native AVFs, pharmacomechanical thrombectomy and thrombolysis with balloon maceration provide similar safety profiles and long-term patency outcomes. Patency and reintervention are primarily influenced by thrombus load, access anatomy, and patient-related factors rather than device selection, supporting a lesion-oriented and individualized endovascular treatment strategy.
No takes yet. Share an insight, caveat, or question.
Dilek et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: